Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
Past Issue

Vol. 11, No. 2
February 2005

EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

Comments Comments



Appendix Table 1
Appendix Table 2
Appendix Table 3
Back to article

Research

Sporadic Cryptosporidiosis Decline after Membrane Filtration of Public Water Supplies, England, 1996–2002

Stella Goh,* Mark Reacher,†Comments David P. Casemore,‡ Neville Q. Verlander,§ André Charlett,§ Rachel M. Chalmers,¶ Margaret Knowles,# Anthony Pennington,* Joy Williams,* Keith Osborn,** and Sarah Richards††
*Carlisle and District Primary Care Trust, Carlisle, United Kingdom; †Health Protection Agency, Cambridge, United Kingdom; ‡University of Wales, Aberystwyth, Ceredigion, Wales, United Kingdom; §Health Protection Agency Centre for Infections, Colindale, London, United Kingdom; ¶Singleton Hospital, Swansea, Wales, United Kingdom; #Cumberland Infirmary, Carlisle, United Kingdom; **United Utilities, Great Sankey, Warrington, United Kingdom; and ††West Cumberland Hospital, Whitehaven, United Kingdom


Appendix

Appendix Table 1. Water sources, water distribution zones, filtration, and populations served, Copeland and Allerdale Local Authorities, 1996–2002

Water sources

Water zones

Filtration of water supplies

Average population


Crummock Lake

Crummock North
Crummock South

Unfiltered March 1, 1996–February 29, 2000;
membrane filtration from March 1, 2000, to August 31, 2002

58,295

Ennerdale Lake

Ennerdale North
Ennerdale South

Unfiltered March 1, 1996–February 29, 2000;
membrane filtration from March 1, 2000, to August 31, 2002

47,780

"Other*"

Millom
Quarry Hill
Hausegill
Hayknott
Underscar
Bridgend
Fellside
Multiple sources
Private

Conventionally filtered* throughout the study
period (March 1, 1996–August 31, 2002)

59,699


*A variety of conventionally treated and unfiltered water, and private supplies.

 

Appendix Table 2. Symptoms and duration of symptoms in case-patients

Characteristics

n (%)


Before membrane filtration

After membrane filtration

Before and after membrane filtration




March 1, 1996–February 29, 2000

March 1, 2000–August 31, 2002

March 1, 1996–August 31, 2002


Symptoms

   Diarrhea

153 (100)

22 (100)

175 (100)

   Vomiting

94 (61.4)

10 (45.5)

104 (59.4)

   Abdominal pain

110 (71.9)

18 (81.8)

128 (73.1)

   Fever

69 (45.1)

9 (40.9)

78 (44.6)

   Loss of appetite

68 (44.4)

18 (81.8)

86 (49.1)

   Weight loss

56 (36.6)

17 (77.3)

73 (41.7)

Symptoms at interview

38 (24.8)

4 (18.2)

42 (24.0)

No symptoms at interview

115 (75.2)

18 (81.8)

133 (76.0)

Median days* symptomatic

9

10

9

Range

2–21

3–20

2–21


*Of patients without symptoms at interview.

 

Appendix Table 3. Admissions to hospital by age and sex

Characteristics

Before membrane filtration

After membrane filtration

Before and after membrane filtration




March 1, 1996–February 29, 2000

March 1, 2000–August 31, 2002

March 1, 1996–August 31, 2002




Total

Admitted

%

Total

Admitted

%

Total

Admitted

%


Female

   <1–5 y

34

5

15

7

1

14

41

6

15

   6–15 y

22

2

9

4

1

25

26

3

12

   Total >1–15 y

56

7

13

11

2

18

67

9

13

Male

   <1–5 y

53

14

26

2

0

0

55

14

25

   6–15 y

25

2

8

3

1

33

28

3

11

   Total <1–15 y

78

16

21

5

1

20

83

17

20

F and M

   <1–5 y

87

19

22

9

1

11

96

20

21

   6–15 y

47

4

9

7

2

29

54

6

11

   Total <1–15 y

134

23

17

16

3

19

150

26

17


 

Appendix Table 4. Speciation of Cryptosporidium isolates

Isolates

n (%)


Before membrane filtration

After membrane filtration

Before and after membrane filtration




January 1, 1998–February 29, 2000

March 1, 2000–August 31, 2002

January 1, 1998–August 31, 2002


Total speciated

68 (100)

16 (100)

84 (100)

C. hominis

1 (1.5)

3 (18.8)

4 (4.8)

C. parvum

57 (83.8)

13 (81.2)

70 (83.3)

Not determined

10 (14.7)

0 (0)

10 (11.9)


   
     
   
Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Mark Reacher, Health Protection Agency, East of England, Institute of Public Health, University Forvie Site, Robinson Way, Cambridge CB2 2SR, United Kingdom; fax: 44 0 1223 331865; email: mreacher@hpa.org.uk

Please note: To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.

Return email address optional:


 


Comments to the EID Editors
Please contact the EID Editors at eideditor@cdc.gov

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page posted January 6, 2005
This page last reviewed January 6, 2005

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention